Docket Management
Docket: 00N-1269 - Labeling for Human Prescription Drug/Biologic Products
Comment Number: EC -20

Accepted - Volume 4

Comment Record
Commentor Dr. Claire Wolfe Date/Time 2001-05-21 11:42:08
Organization Ohio State Medical Association member
Category Health Professional

Comments for FDA General
Questions
1. General Comments I like the proposal to simpify the product insert information for physicians. The pertinent information should be short, to the point, bulletted i.e. we don't need full sentences. Physicians are used to looking at vertically written lists. It should include: indications; contraindications; drug interactions; dosages; MOST COMMON, i.e. most likely, side effects.




EC -20